SEC Filing Summary: Landec Corporation (Form 8-K)
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Landec Corporation on September 3, 2014. The filing reports a significant corporate governance event regarding the executive leadership team. Note: The request metadata referenced "LIFECORE BIOMEDICAL, INC.", but the source text explicitly identifies the registrant as Landec Corporation.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on personnel changes and does not contain financial statements or performance data.
Material Changes
- Executive Departure: Gary T. Steele announced his retirement as President, Chief Executive Officer (CEO), and Chairman of the Board.
- Effective Date: The retirement is scheduled to take effect on May 31, 2015, coinciding with the end of the Company's fiscal year.
- Board Continuity: Mr. Steele has agreed to remain on the Board of Directors following his retirement from executive roles.
Guidance, Outlook, and Risks
The filing does not contain updated financial guidance, management commentary on future outlook, or specific risk factors related to the departure. The document serves as a formal notification of the leadership transition plan.
Investor Verification Checklist
- Verify the appointment of an interim or permanent successor to the CEO and President roles.
- Confirm the timeline for the transition of duties between Mr. Steele and the incoming leadership.
- Review subsequent filings for any changes to the Board composition or executive compensation arrangements.